Spotlight: Partnering and More in Boston

Biotech Week Boston headlines a special week of events

The week of September 25-29 in Boston is continuing to grow with more and more industry events, dealmaking, and networking opportunities for life science companies and organizations around the world. This week has become one of the main “big” international gathering weeks for industry professionals, joining January’s BioWeekSF/JPM Week in San Francisco and BIO’s International Convention week in the summer, which just finished in San Diego (and will be in Boston for 2018.) We will have special coverage of what we’re calling BioBoston 2017 (#BioBoston17) before and through the week; the showcase events include:

  • RESI Conference (Sept 26)
    The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring products to market at a faster pace. RESI brings qualified investors from ten categories including, Family Offices, Venture Philanthropy, Patient Groups, Corporate Development, Virtual Pharma, Endowments, Foundation, and Angels.
    More information

ADDITIONAL EVENTS

  • Cell & Gene Therapy CEO (Sept 25) – This networking forum brings together CEOs and decision makers in cell therapy, gene therapy, and regenerative medicine. Intimate discussion panels, keynotes and fireside chats feature thought leaders debating business model efficiencies, financing, regulatory issues, market access and reimbursement, novel partnerships, manufacturing and delivery challenges.
    More information

  • FierceBiotech 2nd Drug Development Forum (Sept 25-27) – Biopharma companies must increasingly adopt creative dealmaking, new digital technologies and early cost-effectiveness strategies, all while speeding up the R&D process. This requires a novel way of thinking about partnerships and pipeline strategies, from the highest levels of biopharma leadership. The FierceBiotech 2nd Drug Development Forum draws together the industry’s executive decision-makers, to help guide your companies to success throughout the entire lifecycle – both for products and for companies themselves.
    More information

  • Discovery on Target (Sept 25-29) – Cambridge Healthtech Institute’s 15th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets”, will once again gather over 1,200 drug discovery professionals; the event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.
    More information
  • American Pharma Outsourcing Summit (Sept 27-28) – The summit is designed to provide pharmaceutical outsourcing executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics. This unique summit brings together manufacturing and supply chain-focused leaders involved in the business of pharmaceutical outsourcing.
    More information

  • MassBIO CRO/CMO Symposium (Sept 28) – MassBio’s 6th annual CRO/CMO Symposium is breaking new ground — it’s also joined forces with BWB to form this year’s event, Connecting Buyers and Sellers. This symposium has historically gathered over 300 attendees to discuss and evaluate the best practices that have evolved in shortening time to market.
    More information
  • Xconomy Presents Boston’s Life Science Disruptors (Sept 28) – This is an annual evening event featuring candid stories from some of New England’s most radical company leaders, founders, and VC backers out to change the game in biotech. This event is also associated with BWB.
    More information